Please use this identifier to cite or link to this item:
http://localhost:8080/xmlui/handle/123456789/1901
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ichikawa, H | - |
dc.contributor.author | Mangalam S Nair | - |
dc.contributor.author | Takada, Y | - |
dc.contributor.author | Alan Sheeja, D B | - |
dc.contributor.author | Suresh Kumar, M A | - |
dc.contributor.author | Oommen, O V | - |
dc.contributor.author | Aggarwal, B B | - |
dc.date.accessioned | 2015-08-06T05:37:53Z | - |
dc.date.available | 2015-08-06T05:37:53Z | - |
dc.date.issued | 2006 | - |
dc.identifier.citation | Clinical Cancer Research 12(19):5910-5918;1 Oct 2006 | en_US |
dc.identifier.issn | 1078-0432 | - |
dc.identifier.uri | http://ir.niist.res.in:8080/jspui/handle/123456789/1901 | - |
dc.description.abstract | Purpose: Deoxyelephantopin (ESD) and isodeoxyelephantopin (ESI) are two sesquiterpene lactones derived from the medicinal plant Elephantopus scaber Linn. (Asteraceae). Although they are used for the treatment of a wide variety of proinflammatory diseases, very little is known about their mechanism of action. Because most genes that control inflammation are regulated by activation of the transcription factor nuclear factor-kappa B (NF-kappa B), we postulated that ESD and ESI mediate their activities through modulation of the NF-kappa B activation pathway. Experimental Design: We investigated the effect of ESI and ESD on NF-kappa B activation by electrophoretic mobility shift assay and NF-kappa B-regulated gene expression by Western blot analysis. Results: We found that ESI suppressed NF-kappa B activation induced by a wide variety of inflammatory agents, including tumor necrosis factor (TNF), interleukin-1 beta phorbol 12-myristate 13-acetate, and lipopolysaccharide. The suppression was not cell type specific, and both inducible and constitutive NF-kappa B activation was blocked. ESI did not interfere with the binding of NF-kappa B to DNA but rather inhibited I kappa B alpha kinase, I kappa B alpha phosphorylation, I kappa B alpha degradation, p65 phosphorylation, and subsequent p65 nuclear translocation. ESI also suppressed the expression of TNF-induced NF-kappa B-regulated, proliferative, antiapoptotic, and metastatic gene products. These effects correlated with enhancement of apoptosis induced by TNF and suppression of TNF-induced invasion and receptor activator of NF-kappa B ligand-induced osteoclastogenesis. Conclusion: Our results indicate that ESI inhibits NF-kappa B activation and NF-kappa B-regulated gene expression, which may explain the ability of ESI to enhance apoptosis and inhibit invasion and osteoclastogenesis. | en_US |
dc.language.iso | en | en_US |
dc.publisher | American Association for Cancer Research | en_US |
dc.subject | Tumor-necrosis-factor | en_US |
dc.subject | Alpha-induced apoptosis | en_US |
dc.subject | Transcription factor | en_US |
dc.subject | P65 phosphorylation | en_US |
dc.title | Isodeoxyelephantopin, a novel sesquiterpene lactone, potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis through suppression of nuclear factor-kappa B (NF-kappa B) activation and NF-kappa B-regulated gene expression | en_US |
dc.type | Article | en_US |
Appears in Collections: | 2006 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
2006_0045.PDF Restricted Access | 594.3 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.